Alpha 2.0
Login Register
» Authors » Edoardo Caporusso

Edoardo Caporusso

Explore the profile of Edoardo Caporusso including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 13
Citations 56
Followers 0
Related Specialties
Psychiatry
Neurology
General Medicine
Top 10 Co-Authors
Silvana Galderisi
Luigi Giuliani
Armida Mucci
Paola Bucci
Pasquale Pezzella
Giulia Maria Giordano
Paola Rocca
Mario Maj
Alessandro Rossi
Alessandro Bertolino
Published In
Eur Psychiatry
Front Psychiatry
Eur Arch Psychiatry Clin Neurosci
Schizophr Bull Open
Expert Rev Neurother
Affiliations
Soon will be listed here.
Recent Articles
1.
Investigating the causal pathways among psychopathological variables, cognitive impairment, and real-life functioning in people with schizophrenia
Giuliani L, Sanmarchi F, Mucci A, Rucci P, Caporusso E, Bucci P, et al.
Schizophrenia (Heidelb) . 2025 Jan; 11(1):1. PMID: 39753575
The present study aimed to investigate the causal relationships among cognitive impairment, psychopathology, and real-life functioning in a large sample of people with schizophrenia, using a data-driven causal discovery procedure...
2.
Effectiveness of a social cognition remediation intervention for patients with schizophrenia: a randomized-controlled study
Giuliani L, Pezzella P, Mucci A, Palumbo D, Caporusso E, Piegari G, et al.
Ann Gen Psychiatry . 2024 Dec; 23(1):52. PMID: 39732701
This randomized-controlled study evaluates the effectiveness of a newly developed social cognition rehabilitation intervention, the modified Social Cognition Individualized Activity Lab (mSoCIAL), in improving social cognition and clinical and functional...
3.
Research evidence on the management of the cognitive impairment component of the post-COVID condition: a qualitative systematic review
Melillo A, Perrottelli A, Caporusso E, Coltorti A, Giordano G, Giuliani L, et al.
Eur Psychiatry . 2024 Sep; 67(1):e60. PMID: 39328154
Background: Cognitive impairment (CI) is one of the most prevalent and burdensome consequences of COVID-19 infection, which can persist up to months or even years after remission of the infection....
4.
Interview Versus Performance Assessment of Cognition as Predictors of Real-World Outcomes in a Large-Scale Cross-Sectional Study in Schizophrenia
Pezzella P, Caporusso E, Mucci A, Bucci P, Giordano G, Amore M, et al.
Schizophr Bull Open . 2024 Sep; 5(1):sgae020. PMID: 39221412
The Cognitive Assessment Interview (CAI) is an interview-based scale measuring cognitive impairment and its impact on functioning in subjects with schizophrenia (SCZ). It is approved as a coprimary measure of...
5.
The relationship between the resting state functional connectivity and social cognition in schizophrenia: Results from the Italian Network for Research on Psychoses
Rocca P, Brasso C, Montemagni C, Del Favero E, Bellino S, Bozzatello P, et al.
Schizophr Res . 2024 Apr; 267:330-340. PMID: 38613864
Deficits in social cognition (SC) interfere with recovery in schizophrenia (SZ) and may be related to resting state brain connectivity. This study aimed at assessing the alterations in the relationship...
6.
Advances in the understanding of the pathophysiology of schizophrenia and bipolar disorder through induced pluripotent stem cell models
Perrottelli A, Marzocchi F, Caporusso E, Giordano G, Giuliani L, Melillo A, et al.
J Psychiatry Neurosci . 2024 Mar; 49(2):E109-E125. PMID: 38490647
The pathophysiology of schizophrenia and bipolar disorder involves a complex interaction between genetic and environmental factors that begins in the early stages of neurodevelopment. Recent advancements in the field of...
7.
External validation of the five domains of negative symptoms: Focus on cognition, functional capacity, and real-world functioning
Giordano G, Sanmarchi F, Mucci A, Rucci P, Brando F, Caporusso E, et al.
Eur Psychiatry . 2023 Dec; 67(1):e3. PMID: 38097401
Background: The conceptualization of negative symptoms (NS) in schizophrenia is still controversial. Recent confirmatory factor-analytic studies suggested that the bi-dimensional model (motivational deficit [MAP] and expressive deficit [EXP]) may not...
8.
Correlations between Negative Symptoms and Cognitive Deficits in Individuals at First Psychotic Episode or at High Risk of Psychosis: A Systematic Review
Melillo A, Caporusso E, Giordano G, Giuliani L, Pezzella P, Perrottelli A, et al.
J Clin Med . 2023 Nov; 12(22). PMID: 38002707
The present review aims to identify correlations between negative symptoms (NS) and deficits in neurocognition and social cognition in subjects with first-episode psychosis (FEP) and at-high-risk populations (HR). A systematic...
9.
The structure stability of negative symptoms: longitudinal network analysis of the Brief Negative Symptom Scale in people with schizophrenia
Rucci P, Caporusso E, Sanmarchi F, Giordano G, Mucci A, Giuliani L, et al.
BJPsych Open . 2023 Sep; 9(5):e168. PMID: 37674282
Background: The structure of negative symptoms of schizophrenia is still a matter of controversy. Although a two-dimensional model (comprising the expressive deficit dimension and the motivation and pleasure dimension) has...
10.
Insight in cognitive impairment assessed with the Cognitive Assessment Interview in a large sample of patients with schizophrenia
Bucci P, Mucci A, Giordano G, Caporusso E, Giuliani L, Gibertoni D, et al.
Eur Arch Psychiatry Clin Neurosci . 2023 Jun; 274(6):1343-1354. PMID: 37380743
The Cognitive Assessment Interview (CAI) is an interview-based scale measuring cognitive impairment and its impact on functioning in subjects with schizophrenia (SCZ). The present study aimed at assessing, in a...